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1 AN ACT 
2 relating to health benefit plan coverage for orally administered 
3 anticancer medications. 
4 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: 
5 SECTION 1. Chapter 1369, Insurance Code, is amended by 
6 adding SubchapteI' E to read as follows: 
7 SUBCHAPTER E. COVERAGE FOR ORALLY ADMINISTERED ANTICANCER 
8 MEDICATIONS 
9 Sec. 1369.201. DEFINITIONS. In this subchapter: 
10 (1) "Health benefit exchange" means an American Health 
11 Benefit Exchange administered by the federal government or created 
, , 
12 pursuant to Section 1311(b), Patient Protection and Affordable Care 
13 Act (42 U.S.C. Sec:tion 18031). 
14 (2) "Qualified health plan" has the meaning assigned 
15 by Section 1301(a), Patient Protection and Affordable Care Act (42 
16 U.S.C. Section 18021). 
17 Sec. 1369.202. APPLICABILITY OF SUBCHAPTER. This 
18 subchapter applies only to a health benefit plan, including a small 
19 employer health b:enefit plan wr itt en under Chapter 1501 or coverage 
20 provided by a health group cooperative under Subchapter B of that 
21 chapter, that provides benefits for medical or surgical expenses 
22 incurred as a res,ult of a health condition, accident, or sickness, 
23 including an individual, group, blanket, or franchise insurance 
24 policy or insurance agreement, a ,group hospital service contract, 
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1 or an individual or group evidence of coverage or similar coverage 
2 document that is offered by: 
3 
4 
(1) an insurance company; 
(2) a group hospital service corporation operating 






















a fraternal benefit society operating under 
a stipulated premium company operating under 
an exchange operating under Chapter 942; 
a Lloyd's plan operating under Chapter 941; 
a health maintenance organization operating under 
an approved nonprofit health corporation that 
15 holds a certificate of authority under Chapter 844. 
16 Sec. 1369.203. EXCEPTION. (a) This subchapter does not 
17 apply to: 
18 
19 
(1) a plan that provides coverage: 
(A) only for fixed indemnity benefits for a 
20 specified disease or diseases; 
21 
22 
(B) only for accidental death or dismemberment; 
(C) for wages or payments in lieu of wages for a 
23 period during which an employee is absent from work because of 




(0) as a supplement to a liability insurance 
(E) only for dental or vision care; or 
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1 (F) only for indemnity for hospital confinement; 
2 (2) a Medicare supplemental policy as defined by 
3 Section l882(g) (1), Social Security Act (42 U.S.C. Section 1395ss); 
4 (3) a workers' compensation insurance pOlicy; 
5 (4) medical payment insurance coverage provided under 
6 an automobile insurance pOlicy; 
7 
8 
(5) a credit insurance policy; 
(6) a limited benefit pOlicy that does not provide 
9 coverage for physical examinations or wellness exams; 
10 (7) a multiple employer welfare arrangement that holds 
11 a certificate of authority under Chapter 846; or 
12 (8) a long-term care insurance pOlicy, including a 
13 nursing home fixed indemnity policy, unless the commissioner 
14 determines that the policy provides benefit coverage so 
15 comprehensive that the policy is a health benefit plan as described 
16 by Section 1369.201-
17 (b) This subchapter does not apply to a qualified health 
18 plan offered throUgh a health benefit exchange. 
19 Sec. 1369.204. REQUIRED COVERAGE FOR ORALLY ADMINISTERED 
20 ANTICANCER MEDICATIONS. (a) A health benefit plan that provides 
21 coverage for cancer treatment must provide coverage for a 
22 prescribed, orally administered anticancer medication that is used 
23 to kill or slow the growth of cancerous cells on a basis no less 
24 favorable than intravenously administered or injected cancer 
25 medications that are covered as medical benefits by the plan. 
26 (b) This section does not prohibit a health benefit plan 
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If an orally administered anticancer 
medication is authorized, the cost to the covered individual may 
not exceed the coinsurance or copayment that would be applied to a 
4 chemotherapy or other cancer treatment visit. 
5 (c) A health benefit plan issuer may not reclassify 
6 anticancer medications or increase a coinsurance, copayment, 
7 deductible, or o.ther out-of-pocket expense imposed on anticancer 
8 medications to achieve compliance with this section. Any plan 
9 change that otherwise increases an out-of-pocket expense applied to 
10 anticancer medications must also be applied to the majority of 
11 comparable medical or pharmaceutical benefits under the plan. 
12 (d) This section does not prohibit a health benefit plan 
13 issuer from increasing cost-sharing for all benefits, including 
14 ant icancer tr eatments. 
15 SECTION 2. Subchapter E, Chapter 1369, Insurance Code, as 
16 added by this Act, applies only to a health benefit plan that is 
17 delivered, issued for.delivery, or-renewed on or after January 1', 
18 2012. A health benefit plan that is delivered, issued for delivery, 
19 or renewed before January 1, 2012, is covered by the law in effect 
20 at the time the plan was delivered, issued for delivery, or renewed, 
21 and that law is continued in effect for that purpose. 
22 SECTION 3. This Act takes effect September 1, 2011. 
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President of the Senate peaker of the House 
I certify that H.B. No. 438 was passed by the House on April 
21, 2011, by the following vote: Yeas 147, Nays 1, 1 present, not 
voting. 
Chief Clerk of the H 
I certify that H.B. No. 438 was passed by the Senate on May 
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